Skin Boosters
AQUASHINE references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
CE Marked
SKU 11122
Aquashine HA
In stock
Volume
1 x 2 mL
Laboratory
Caregen Co., Ltd.
Origin
South Korea
Indication
Skin hydration, revitalization and age-related correction
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.
Aquashine HA (Revofil Aquashine HA) is a sterile injectable intradermal implant based on cross-linked hyaluronic acid, manufactured by Caregen Co., Ltd. in South Korea. The sodium hyaluronate is of non-animal, biosynthetic origin and is cross-linked with BDDE (residual BDDE below 1 ppm). Placed in the middle and superficial dermis, the gel binds water in the tissue to smooth wrinkles and folds, restore dermal density and the facial oval, and provide deep hydration. It is CE-marked and supplied for professional use by appropriately trained practitioners only.
Note: The manufacturer does not currently list this reference on their website. Please confirm current availability with ALLPARA before purchasing.
Key Benefits of Aquashine HA
- Cross-linked hyaluronic acid at 15 mg/ml (sodium hyaluronate), of non-animal biosynthetic origin
- Placed in the middle and superficial dermis to restore dermal density and smooth wrinkles and folds
- Restores the skin's hydrobalance and supports lifting and restoration of the facial oval
- Suited to the nasolabial and oral-chin folds, chin and cheekbones
- Supplied as a 3 ml syringe filled with 2 ml of gel, with two sterile 30G 13 mm needles
- Manufactured by Caregen Co., Ltd. (South Korea); CE-marked, single use only
Indications and Professional Use
Main indications
- Correction of wrinkles and folds of the facial tissues
- Restoration and modelling of volume, and replenishment of missing tissue volume
- Restoration of the skin's hydrobalance and tissue structure
- Correction of the shape and volume of the lips, cheekbones and facial oval
- Rejuvenation of the hands
- Hydration and rejuvenation of the skin
Professional use
Aquashine HA is intended for administration only by qualified medical personnel trained in intradermal injection technique, using aseptic technique. The manufacturer specifies placement in the middle and superficial dermis using the supplied 30G (0.30 x 13 mm) needle, by linear (threading), linear-point, point or grid technique. It must not be combined with implants or gels from other manufacturers in a single procedure; injection into the eyelids and intravascular injection are strictly prohibited. Single use, one patient only; do not re-sterilise. Patient selection, injection technique and aftercare remain the responsibility of the treating practitioner.
Treatment areas
- Nasolabial folds
- Oral-chin (labiomental) folds
- Chin
- Cheekbones
Patient profile
Suitable for adult patients seeking correction of wrinkles and folds, restoration of hydrobalance and dermal structure, and rejuvenation of the skin, as assessed by a qualified practitioner. Contraindicated in pregnancy and lactation, allergy to any component, systemic retinoid, anticoagulant/antithrombotic or immunosuppressive therapy, inflammatory infiltrates, progressive chronic dermatoses, herpetic infection, paraneoplastic processes at the injection site, and decompensated severe somatic disease. In patients under 18, only with the consent of a legal representative.
How Aquashine HA Works
Aquashine HA is a cross-linked hyaluronic acid gel at 15 mg/ml of sodium hyaluronate in a phosphate buffer. Placed in the middle and superficial dermis, the cross-linked hyaluronic acid binds water in the tissue, so the effect is restored moisture, improved dermal density and smoothing of wrinkles and folds rather than deep volumising. The manufacturer reports full resorption at approximately one month, with the aesthetic effect retained from one to six months depending on the skin, the wrinkle and the technique used.
Why Order From Allpara
Allpara offers genuine, verified AQUASHINE products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
What is in Aquashine HA?
Cross-linked sodium hyaluronate at 15 mg/ml in a phosphate buffer, of non-animal biosynthetic origin, cross-linked with BDDE (residual BDDE below 1 ppm). The manufacturer's Instructions for Use list no peptides, vitamins or amino acids in this reference.
Where is Aquashine HA injected?
Into the middle and superficial dermis, using the supplied 30G 13 mm needle. It is directed at the nasolabial and oral-chin folds, the chin and the cheekbones.
How does Aquashine HA differ from Aquashine HA BR?
Aquashine HA is the 15 mg/ml, medium-viscosity variant (25.0 Pa·s), directed at the nasolabial and oral-chin folds, the chin and the cheekbones. Aquashine HA BR is the 13 mg/ml, lower-viscosity variant (18.0 Pa·s), directed at the periorbital zone, neck, lips and forehead.
More from Caregen
Dermal Fillers
DR. CYJ references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
DR. CYJ Products
View all 1
REVOFIL references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
REVOFIL Products
View all 3
Clinic alternatives
Biorevitalisation
Mesotherapy
/ Recently viewed
Pick up where you left off
Aquashine HA
In stock
CE Marked
Aquashine HA (Revofil Aquashine HA) is a sterile injectable intradermal implant based on cross-linked hyaluronic acid, manufactured by Caregen Co., Ltd. in South Korea. The sodium hyaluronate is of non-animal, biosynthetic origin and is cross-linked with BDDE (residual BDDE below 1 ppm). Placed in the middle and superficial dermis, the gel binds water in the tissue to smooth wrinkles and folds, restore dermal density and the facial oval, and provide deep hydration. It is CE-marked and supplied for professional use by appropriately trained practitioners only.
Note: The manufacturer does not currently list this reference on their website. Please confirm current availability with ALLPARA before purchasing.
Key Benefits of Aquashine HA
- Cross-linked hyaluronic acid at 15 mg/ml (sodium hyaluronate), of non-animal biosynthetic origin
- Placed in the middle and superficial dermis to restore dermal density and smooth wrinkles and folds
- Restores the skin's hydrobalance and supports lifting and restoration of the facial oval
- Suited to the nasolabial and oral-chin folds, chin and cheekbones
- Supplied as a 3 ml syringe filled with 2 ml of gel, with two sterile 30G 13 mm needles
- Manufactured by Caregen Co., Ltd. (South Korea); CE-marked, single use only
Indications and Professional Use
Main indications
- Correction of wrinkles and folds of the facial tissues
- Restoration and modelling of volume, and replenishment of missing tissue volume
- Restoration of the skin's hydrobalance and tissue structure
- Correction of the shape and volume of the lips, cheekbones and facial oval
- Rejuvenation of the hands
- Hydration and rejuvenation of the skin
Professional use
Aquashine HA is intended for administration only by qualified medical personnel trained in intradermal injection technique, using aseptic technique. The manufacturer specifies placement in the middle and superficial dermis using the supplied 30G (0.30 x 13 mm) needle, by linear (threading), linear-point, point or grid technique. It must not be combined with implants or gels from other manufacturers in a single procedure; injection into the eyelids and intravascular injection are strictly prohibited. Single use, one patient only; do not re-sterilise. Patient selection, injection technique and aftercare remain the responsibility of the treating practitioner.
Treatment areas
- Nasolabial folds
- Oral-chin (labiomental) folds
- Chin
- Cheekbones
Patient profile
Suitable for adult patients seeking correction of wrinkles and folds, restoration of hydrobalance and dermal structure, and rejuvenation of the skin, as assessed by a qualified practitioner. Contraindicated in pregnancy and lactation, allergy to any component, systemic retinoid, anticoagulant/antithrombotic or immunosuppressive therapy, inflammatory infiltrates, progressive chronic dermatoses, herpetic infection, paraneoplastic processes at the injection site, and decompensated severe somatic disease. In patients under 18, only with the consent of a legal representative.
How Aquashine HA Works
Aquashine HA is a cross-linked hyaluronic acid gel at 15 mg/ml of sodium hyaluronate in a phosphate buffer. Placed in the middle and superficial dermis, the cross-linked hyaluronic acid binds water in the tissue, so the effect is restored moisture, improved dermal density and smoothing of wrinkles and folds rather than deep volumising. The manufacturer reports full resorption at approximately one month, with the aesthetic effect retained from one to six months depending on the skin, the wrinkle and the technique used.
Why Order From Allpara
Allpara offers genuine, verified AQUASHINE products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
What is in Aquashine HA?
Cross-linked sodium hyaluronate at 15 mg/ml in a phosphate buffer, of non-animal biosynthetic origin, cross-linked with BDDE (residual BDDE below 1 ppm). The manufacturer's Instructions for Use list no peptides, vitamins or amino acids in this reference.
Where is Aquashine HA injected?
Into the middle and superficial dermis, using the supplied 30G 13 mm needle. It is directed at the nasolabial and oral-chin folds, the chin and the cheekbones.
How does Aquashine HA differ from Aquashine HA BR?
Aquashine HA is the 15 mg/ml, medium-viscosity variant (25.0 Pa·s), directed at the nasolabial and oral-chin folds, the chin and the cheekbones. Aquashine HA BR is the 13 mg/ml, lower-viscosity variant (18.0 Pa·s), directed at the periorbital zone, neck, lips and forehead.
More from Caregen
View laboratory →* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.